Physicians Thwart Guidelines, Choose Menopause Bioidenticals

medscape

 According to a recent survey conducted by the North American Menopause Society (NAMS), 41% of patients are choosing compounded, non-FDA-approved preparations, despite society recommendations against them, as previously reported by Medscape Medical News.